Skylands Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
12,931
+2,810
+28% +$258K 0.15% 100
2025
Q4
$910K Buy
10,121
+6,360
+169% +$603K 0.12% 105
2025
Q3
$370K Sell
3,761
-20,100
-84% -$1.99M 0.05% 126
2025
Q2
$2.18M Buy
23,861
+15,325
+180% +$1.48M 0.32% 74
2025
Q1
$966K Buy
8,536
+1,550
+22% +$166K 0.14% 105
2024
Q4
$738K Buy
6,986
+3,261
+88% +$350K 0.1% 108
2024
Q3
$402K Buy
+3,725
New +$407K 0.05% 124
2017
Q1
Sell
-4,944
Closed -$495K 188
2016
Q4
$495K Buy
4,944
+4,429
+860% +$475K 0.08% 133
2016
Q3
$65K Hold
515
0.01% 172
2016
Q2
$60K Hold
515
0.01% 177
2016
Q1
$53K Hold
515
0.01% 178
2015
Q4
$51K Hold
515
0.01% 193
2015
Q3
$47K Buy
515
+206
+67% +$20.7K 0.01% 210
2015
Q2
$34K Sell
309
-206
-40% -$22.8K ﹤0.01% 224
2015
Q1
$59K Hold
515
0.01% 217
2014
Q4
$57K Buy
515
+206
+67% +$21.7K 0.01% 215
2014
Q3
$30K Sell
309
-206
-40% -$20.3K ﹤0.01% 238
2014
Q2
$52K Hold
515
0.01% 241
2014
Q1
$47K Hold
515
﹤0.01% 217
2013
Q4
$47K Buy
515
+206
+67% +$17.8K 0.01% 212
2013
Q3
$25K Hold
309
﹤0.01% 219
2013
Q2
$22K Buy
+309
New +$23.1K ﹤0.01% 214

Other funds holding ZBH

Skylands Capital's ZBH Position: Q1 2026 in Review

Skylands Capital increased its Zimmer Biomet (ZBH) stake by 28% in Q1 2026, buying an estimated $258K and bringing the position to 12,931 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #100.

Skylands Capital first reported a position in ZBH in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.18M in Q2 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Skylands Capital held 12,931 shares of Zimmer Biomet worth $1.17M as of Q1 2026.
  • Skylands Capital bought 2,810 Zimmer Biomet shares in Q1 2026, an estimated $258K.
  • Zimmer Biomet made up 0.15% of Skylands Capital's portfolio in Q1 2026, its #100 holding.
  • Skylands Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 22 quarters since.
  • Skylands Capital's Zimmer Biomet position peaked at $2.18M in Q2 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Skylands Capital's 13F filing for Q1 2026, filed 22 Apr 2026.